Virtual Global Expert Program: Patrice Milos

​Sharing real-world experience in supporting pharma/biotech innovators, we will explore:

• ​​An overview of pharmaceutical drug development timelines.

• ​The dramatic inflection of novel sequencing technologies, their development and application to rare disease gene identification.

• ​​The role of molecular diagnostics, including point-of-care, in identifying causative gene mutations.

• ​The emergence of gene therapy and other novel modalities to treat rare diseases.